Expression Profiles of Long Non-Coding RNA GAS5 and MicroRNA-222 in Younger AML Patients

Acute myeloid leukemia (AML) is a heterogeneous malignant disease both on clinical and genetic levels. AML has poor prognosis and, therefore, there is a constant need to find new prognostic markers, as well as markers that can be used as targets for innovative therapeutics. Recently, the search for...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavlovic, Djordje, Tosic, Natasa, Zukic, Branka, Pravdic, Zlatko, Vukovic, Nada Suvajdzic, Pavlovic, Sonja, Gasic, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774494/
https://www.ncbi.nlm.nih.gov/pubmed/35054253
http://dx.doi.org/10.3390/diagnostics12010086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774494/
https://www.ncbi.nlm.nih.gov/pubmed/35054253
http://dx.doi.org/10.3390/diagnostics12010086

Ejemplares similares